

Needham analyst upgrades Collegium Pharmaceutical to Buy with a $46 target, citing strong 2025 guidance, growth potential, and undervaluation.
You can purchase shares of Collegium Pharmaceutical (NASDAQ:COLL) through any online brokerage.
Other companies in Collegium Pharmaceutical’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Collegium Pharmaceutical has a consensus price target of $47.27.
The stock price for Collegium Pharmaceutical (NASDAQ: COLL) is $23.22 last updated October 27, 2026 at 10:24 AM EDT.
There are no upcoming dividends for Collegium Pharmaceutical.
Collegium Pharmaceutical does not have any upcoming earnings scheduled.
There is no upcoming split for Collegium Pharmaceutical.
Collegium Pharmaceutical is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated...